MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.chembiol.2023.03.002

Медицинская библиотека · Cell chemical biology · 2023

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.

Deni Ioanna, Stokes Barbara H, Ward Kurt E, Fairhurst Kate J, Pasaje Charisse Flerida A, Yeo Tomas, Akbar Shirin, Park Heekuk, Muir Ryan, Bick Daniella S, Zhan Wenhu, Zhang Hao, Liu Yi Jing, Ng Caroline L, Kirkman Laura A, Almaliti Jehad, Gould Alexandra E, Duffey Maëlle, O'Donoghue Anthony J, Uhlemann Anne-Catrin, Niles Jacquin C, da Fonseca Paula C A, Gerwick William H, Lin Gang, Bogyo Matthew, Fidock David A

СтатьяПоддержка правительства СШАПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing with the first-line artemisinin drugs, including against artemisinin-resistant parasites. We compared resistance profiles of vinyl sulfone, epoxyketone, macrocyclic peptide, and asparagine ethylenediamine inhibitors and report that the vinyl sulfones were potent even against mutant parasites resistant to other proteasome inhibitors and did not readily select for resistance, particularly WLL that displays covalent and irreversible binding to the catalytic β2 and β5 proteasome subunits. We also observed instances of collateral hypersensitivity, whereby resistance to one inhibitor could sensitize parasites to distinct chemotypes. Proteasome selectivity was confirmed using CRISPR/Cas9-edited mutant and conditional knockdown parasites. Molecular modeling of proteasome mutations suggested spatial contraction of the β5 P1 binding pocket, compromising compound binding. Dual targeting of P. falciparum proteasome subunits using covalent inhibitors provides a potential strategy for restoring artemisinin activity and combating the spread of drug-resistant malaria.

Для цитирования: Deni Ioanna, Stokes Barbara H, Ward Kurt E, Fairhurst Kate J, Pasaje Charisse Flerida A, Yeo Tomas, Akbar Shirin, Park Heekuk, Muir Ryan, Bick Daniella S, Zhan Wenhu, Zhang Hao, Liu Yi Jing, Ng Caroline L, Kirkman Laura A, Almaliti Jehad, Gould Alexandra E, Duffey Maëlle, O'Donoghue Anthony J, Uhlemann Anne-Catrin, Niles Jacquin C, da Fonseca Paula C A, Gerwick William H, Lin Gang, Bogyo Matthew, Fidock David A. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.. Cell chemical biology. 2023. DOI: 10.1016/j.chembiol.2023.03.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.